Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
| Status: | Recruiting |
|---|---|
| Conditions: | Podiatry |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | May 2011 |
| Contact: | Study Contact |
| Email: | mgsc@studyinbox.com |
An Open-Label Study to Evaluate the Safety of Long-Term Administration of Product 33525 in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris
The purpose of this study is to examine the long-term safety of treating recurrent episodes
of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or
tinea cruris for 7 days for each recurrence with Product 33525.
Inclusion Criteria:
- Evidence of tinea cruris, tinea pedis, or tinea corporis. Additional criteria listed
in protocol
Exclusion Criteria:
- Pregnancy and allergies. Additional criteria listed in protocol
We found this trial at
13
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials